ProCE Banner Activity

Immune Checkpoint Inhibitor in Advanced TNBC

Slideset Download
Download these slides for expert perspectives on incorporating immune checkpoint inhibitor–based therapy into optimal management of advanced/metastatic TNBC, including the biologic rationale, biomarkers for response, and key trial data.

Released: December 08, 2020

Expiration: December 07, 2021

Share

Faculty

Rita Nanda

Rita Nanda, MD

Associate Professor of Medicine
Director, Breast Oncology
Section of Hematology/Oncology
Department of Medicine
The University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Rita Nanda, MD

Associate Professor of Medicine
Director, Breast Oncology
Section of Hematology/Oncology
Department of Medicine
The University of Chicago
Chicago, Illinois